Cefprozil: a review.
Indian J Pediatr
;
2003 May; 70(5): 395-400
Artículo
en Inglés
| IMSEAR
| ID: sea-84439
ABSTRACT
Cefprozil is a novel third generation, broad-spectrum oral cephalosporin with activity against a spectrum of aerobic gram-negative and positive bacteria, as well as certain anaerobes. The beta-lactamase stability of cefprozil may exceed that of other oral cephalosporins for some important pathogens. Cefprozil may be a suitable alternative to several other commonly used beta-lactams and cephalosporins in the treatment of mild to moderate upper and lower respiratory tract infections including sinusitis, otitis media, pharyngitis/tonsillitis, secondary bacterial infection of acute bronchitis, and acute bacterial exacerbations of chronic bronchitis, and skin and skin structure infections in children. Available data indicate the safety of cefprozil in both pediatric and adult population.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Otitis Media
/
Infecciones del Sistema Respiratorio
/
Sinusitis
/
Enfermedades Cutáneas Infecciosas
/
Bronquitis
/
Humanos
/
Faringitis
/
Cefalosporinas
Idioma:
Inglés
Revista:
Indian J Pediatr
Año:
2003
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS